Summary of Purpose
To assess the risks and benefits of administering transdermal nitrous oxide immediately after ischemic and hemorrhagic stroke, and to determine whether or not to continue anti-hypertensive medication taken prior to stroke.Read More →
The following dates are available for this trial. Trial information last updated on 2 March 2010.
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- BUPA Foundation; The Hypertension Trust, University of Nottingham, Medical Research Council.
Prospective, international, multicenter, randomized, controlled, parallel-group, single-blind, collaborative trial.
Sally Utton ENOS Trial Manager Division of Stroke Medicine The University of Nottingham Clinical Sciences Building Nottingham City Hospital Nottingham NG5 1PB www.enos.ac.uk Tel: +44 (0) 115 823 0287 Fax: +44 (0) 115 823 firstname.lastname@example.org